The six recurring line items most patients miss
- Medication: $25–$1,349/mo depending on path.
- Telehealth subscription: $99–$299/mo if the drug price doesn’t include visits.
- Provider visits: quarterly, $75–$300 each.
- Labs: $150–$800/year.
- Supplements: $30–$80/mo (D3, B12, omega-3, electrolytes, protein powder).
- Injection supplies: $10–$25/mo for vials; $0 for pens.
Four common patient paths, all-in
Path A: Commercial covered, Wegovy $25 copay
- Drug $25 + visits $25 + labs $15 + supplements $40 = $105/mo, $6,300 over 5 years.
Path B: Commercial denied, LillyDirect Zepbound
- Drug $499 (10 mg) + visits $50 + labs $20 + supplements $40 + supplies $15 = $624/mo, $37,440 over 5 years.
Path C: Telehealth compounded semaglutide
- Drug+visit bundle $299 + labs $25 + supplements $40 + supplies $15 = $379/mo, $22,740 over 5 years.
Path D: Uninsured Wegovy full list
- Drug $1,349 + visits $83 + labs $50 + supplements $40 = $1,522/mo — not sustainable for most households.
The five-year trap
The biggest financial mistake is budgeting for a “weight-loss course” instead of a chronic medication. STEP 4 showed two-thirds regain within a year of stopping. Plan for 5 years minimum. If the Path B $624/month isn’t sustainable for 60 months, either the price path has to change (PA appeal, manufacturer assistance) or the dose has to change (5 mg maintenance is cheaper than 15 mg).
Prior auth and savings-card stacking — the real money
Nothing in your budget moves as much as insurance status. Wegovy with Novo savings card caps at $0–$25 for covered patients; the same script denied runs $1,349 cash. ~50% of GLP-1 appeals overturn on peer-to-peer alone (2024 KFF analysis). Budget a 60–90 day appeal window and plan a bridge path (LillyDirect, NovoCare, compounded) during it.
Tax-advantaged dollars
HSAs and FSAs can reimburse GLP-1s when prescribed for an eligible condition. For a 24% marginal-federal-bracket household, running $6,000/year through an HSA saves ~$1,440 federal income tax + $460 FICA if W-2 employed — ~30% effective discount. See the HSA/FSA tool.